课题基金 / 基金详情

项目摘要

项目成果

Tamara Danielle Simon的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):脑脊液(CSF)分流术可以使患有脑积水的儿童存活下来,避免持续的脑损伤。脑积水是儿童神经功能障碍的常见原因。然而,脑脊液分流会带来新的慢性外科问题。在初始放置后,由于机械故障,脑脊液分流术通常需要手术翻修。翻修是随后脑脊液分流感染的主要危险因素。脑脊液分流感染治疗需要手术切除脑脊液分流,根据从常规培养中恢复的微生物量身定做两周的静脉抗生素,并进行第二次手术以放置新的脑脊液分流。尽管采取了这种积极的治疗方法,但再感染率从20%到25%不等。提高对感染机制的了解对于有效治疗每年确诊的2,000多例脑脊液分流感染至关重要。我们和其他人已经证明,令人惊讶的是,与首次或随后再次感染相关的患者、内科或手术风险因素很少。然而,间接证据确实表明,在脑脊液分流感染中,微生物或微生物区系的复杂环境,而不是单一的感染生物--表明潜在需要一种新的范式。建议的R01研究计划代表了一种新的范式--从最初的分流到翻修到感染,在脑积水手术过程中表征脑脊液中的微生物区系。我们已经组建了一个具有独特专业知识的团队,采取创新的方法来解决我们对分流性脑积水微生物区系理解的关键差距。我们将使用高通量测序法确定在脑脊液分流感染中检测到的可培养和非可培养微生物DNA的特征,使用细菌DNA聚合酶链式反应定量测定脑脊液中的总细菌负荷,并在可行的情况下使用显微镜来描述这些微生物的生长情况。我们还将利用我们的单中心经验和现有的多中心合作来进行这项前瞻性的多中心研究,收集所有脑脊液分流手术时的临床数据和样本。该应用程序解决了三个具体目标。在目标1中,我们将确认在最初放置脑脊液分流术时没有微生物区系。在目标2中,我们将确定脑脊液分流菌群的进展及其与脑脊液分流感染的关系。在目标3中,我们将确定在连续的分流手术中显著改变脑脊液微生物区系的手术方法。这一模式与标准的脑脊液分流管理不同,对于实质性提高治疗脑脊液分流感染的能力和降低目前不可接受的脑脊液分流感染和再感染率至关重要。这些关键研究将直接为制定针对该微生物区系的新的预防和/或治疗战略提供信息。
英文摘要
 DESCRIPTION (provided by applicant): Cerebrospinal fluid (CSF) shunt placement allows children with hydrocephalus, a common cause of neurological disability in children, to survive and avoid ongoing brain injury. However, CSF shunts cause new chronic surgical problems. After initial placement, CSF shunts often require surgical revision for mechanical failure. Revisions are the major risk factor for subsequent CSF shunt infections. CSF shunt infection treatment requires surgical removal of the CSF shunt, two weeks of intravenous antibiotics tailored to the organism recovered from conventional culture, and a second surgery to place a new CSF shunt. Despite this aggressive treatment, re-infection rates range from 20 to 25%. An improved understanding of the mechanisms of infection is critical to effectively treat over 2,000 CSF shunt infections diagnosed each year. We and others have shown that there are surprisingly few patient, medical, or surgical risk factors associated with either a first or subsequent re-infection. Indirect evidence does, however, point to a role in CSF shunt infection for a complex milieu of microorganisms, or microbiota, rather than a single infecting organism - suggesting the potential need for a new paradigm. The proposed R01 research plan represents a novel paradigm - characterizing the microbiota in CSF across the surgical course of hydrocephalus, from the time of initial shunt placement to revision to infection. We have assembled a team with unique expertise to undertake an innovative approach to address the critical gap in our understanding the microbiota of shunted hydrocephalus. We will characterize the culturable and non-culturable microbial DNA detected in CSF shunt infection using high-throughput sequencing, quantify total bacterial load in CSF using bacterial DNA PCR quantitation, and where feasible use microscopy to describe how these organisms are growing. We will also capitalize upon our single center experience and existing multicenter collaborations to conduct this prospective observational multicenter study collecting clinical data and samples at the time of all CSF shunt surgeries. The application addresses three specific aims. In Aim 1, we will confirm the absence of microbiota at the time of initial CSF shunt placement. In Aim 2, we will determine the progression of CSF shunt microbiota and its association with CSF shunt infection. In Aim 3, we will determine surgical approaches that significantly alter the CSF microbiota across successive shunt surgeries. This paradigm represents a departure from standard CSF shunt management and is critical to substantively advancing our ability to treat CSF shunt infections and reduce the current unacceptably high rates of CSF shunt infection and re-infection. These critical studies will directly inform development of novel prevention and/or treatment strategies that target that microbiota.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-center Studies of Pediatric CSF Shunt Infections
  • 批准号:
    7741525
  • 项目类别:
  • 资助金额:
    $17.88万
  • 财政年份:
    2009
  • 负责人:
    Tamara Danielle Simon
  • 依托单位:
Multi-center Studies of Pediatric CSF Shunt Infections
  • 批准号:
    8290069
  • 项目类别:
  • 资助金额:
    $18.51万
  • 财政年份:
    2009
  • 负责人:
    Tamara Danielle Simon
  • 依托单位:
Multi-center Studies of Pediatric CSF Shunt Infections
  • 批准号:
    8508321
  • 项目类别:
  • 资助金额:
    $18.51万
  • 财政年份:
    2009
  • 负责人:
    Tamara Danielle Simon
  • 依托单位:
Multi-center Studies of Pediatric CSF Shunt Infections
  • 批准号:
    8097507
  • 项目类别:
  • 资助金额:
    $17.19万
  • 财政年份:
    2009
  • 负责人:
    Tamara Danielle Simon
  • 依托单位:
海外基金